HII Names Peter Courtney as Corporate Vice President of Legislative Affairs
ARLINGTON, Va., Jan. 10, 2024 (GLOBE NEWSWIRE) — Global all-domain defense provider HII (NYSE: HII) announced today that Peter Courtney […]
Origin Bancorp, Inc. Announces Fourth Quarter and 2023 Full Year Earnings Release and Conference Call
RUSTON, La., Jan. 10, 2024 (GLOBE NEWSWIRE) — Origin Bancorp, Inc. (NYSE: OBK) (“Origin”), the financial holding company for Origin […]
Toll Brothers New Model Home Opens in Luxury View Community in Camas, Washington
CAMAS, Wash., Jan. 10, 2024 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE: TOL), the nation’s leading builder of luxury homes, announced […]
HII’s Newport News Shipbuilding Delivers First Columbia-class Stern
NEWPORT NEWS, Va., Jan. 10, 2024 (GLOBE NEWSWIRE) — HII’s (NYSE: HII) Newport News Shipbuilding (NNS) division announced today delivery […]
Samuel Adams Debuts ‘Due Date, Brew Date’ to Rally Expecting Couples to Embrace a Booze-Free Bond In Solidarity of Their Pregnant Partner
Boston, Jan. 10, 2024 (GLOBE NEWSWIRE) — We all know expecting mothers can’t drink alcohol, which can be frustrating to […]
Axalta Wins Two 2024 BIG Innovation Awards
Voltatex® 7345 A ECO Wire Enamel enables efficient electric motors, powertrains and energy storage devices, advances electrification, and reduces CO2emissions […]
3D Systems Announces Executive Leadership Changes
ROCK HILL, S.C., Jan. 10, 2024 (GLOBE NEWSWIRE) — 3D Systems (NYSE:DDD) today announced changes in the company’s leadership structure. […]
Inuvo’s IntentKey AI Powers the Privacy-First, Post-Cookie Era
LITTLE ROCK, Ark., Jan. 10, 2024 (GLOBE NEWSWIRE) — In the wake of Google’s phase out of third-party cookies starting […]
DayDayCook Announces Agreement to Acquire 51% of Italian G.L. Industry S.p.A, a Specialized Asian Food Brand
NEW YORK, Jan. 10, 2024 (GLOBE NEWSWIRE) — DDC Enterprise, Ltd., (NYSEAM: DDC) (“DayDayCook,” “DDC,” or the “Company”), a leading […]
AIM ImmunoTech Announces Open Enrollment for Phase 1b/2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer
First enrollment and first subject dosing expected soon at Erasmus Medical Center in Rotterdam, Netherlands Management discusses the announcement and […]
